# Regional analysis of APOE polymorphism in Alzheimer’s disease in Spain

**Authors:** Ignacio Pardo-Pérez, Leticia Sánchez-Valdeón, Ana García-Gallego, Brisamar Estébanez, Inés Casado-Verdejo, Jesús Antonio Fernández-Fernández, Carlos Méndez-Martínez, Laura Bello-Corral

PMC · DOI: 10.1038/s41598-025-98323-2 · Scientific Reports · 2025-04-28

## TL;DR

This study explores how genetic variations in the APOE gene differ across regions in Spain and how these differences may affect Alzheimer's disease risk.

## Contribution

The study reveals regional genetic variability of APOE polymorphisms in Spain, linking it to historical and migratory influences.

## Key findings

- The ε3/ε3 genotype was the most common overall, while ε3/ε4 was prevalent in areas like Ponferrada.
- Soria had no homozygous ε4 individuals, contrasting with higher frequencies in Salamanca.
- Regional genetic patterns suggest historical and migratory influences on Alzheimer's disease risk.

## Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with significant cognitive and functional impacts. Genetic factors, particularly the APOE gene and its allelic variants (ε2, ε3, ε4), play a critical role in AD susceptibility. This study analyzed the allelic frequency and distribution of APOE polymorphisms in three provinces of Castilla y León (León, Soria, Salamanca), Spain, to explore their potential relationship with AD risk. Genotypes were determined using polymerase chain reactions, and statistical analyses revealed significant regional variations. The ε3/ε3 genotype was the most prevalent overall, while the ε3/ε4 genotype predominated in specific areas like Ponferrada. The absence of homozygous ε4 individuals in Soria contrasts sharply with higher frequencies in Salamanca. These differences suggest historical and migratory influences on genetic variability. Identifying regional genetic patterns enhances our understanding of AD risk and supports the development of targeted preventive strategies. Early detection of high-risk alleles could improve patient outcomes, reduce healthcare burdens and inform public health policies.

## Linked entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348]
- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}
- **Diseases:** AD (MESH:D000544), neurodegenerative disorder (MESH:D019636)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12037765/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12037765/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12037765/full.md

---
Source: https://tomesphere.com/paper/PMC12037765